Global Breakthrough Therapy Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

August 2018 | 119 pages | ID: GDB2C42371FGEN
GlobalInfoResearch

Abstracts

Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two factors determine the efficiency of breakthrough therapy drug, they are the magnitude of the treatment effect and observed clinical difference over the existed drug. The standard for breakthrough therapy drug is not same as standard drug approval because, in breakthrough therapy, morbidity and mortality considered for approval of the drug. They are meant to be administered by itself or in combinations. Breakthrough therapy drug development is cost effective due to faster approval of drugs on limited data from the FDA. Manufacturer of breakthrough therapy drugs has to develop additional post-marketing surveillance data for the other reimbursements and market access. Presently available breakthrough therapy medicinal products in the market belong to the treatment class of oncology, infectious diseases, cardiovascular conditions, etc. The designation is given when the drug is in 1st or 2nd stage of clinical trials.

SCOPE OF THE REPORT:

This report focuses on the Breakthrough Therapy Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing prevalence of life-threatening conditions and for the speedy development of pipeline drugs is the primary driver for the breakthrough therapy drugs market. This is because of the high unmet need of presently available treatment for severe conditions. Breakthrough designation of the drug captures the more attention of the manufacturers due to the expedited market access and greater returns on their investments. Because of Breakthrough therapy drugs market are associated with less robust clinical developments. Increasing support of FDA for small scale industries in R&D by providing additional funding and faster approval of drugs fuelling the growth of the breakthrough therapy drugs market. All these factors are boosting the growth of the breakthrough therapy drug market.
Breakthrough therapy designation requires additional planning for the pricing, market access and reimbursements acts as restraints in the growth of the market. Uncertainty around the breakthrough therapy drugs acts as a primary challenge for the manufacturers.

The worldwide market for Breakthrough Therapy Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Merck
• Pfizer
• AbbVie
• Bristol-Myers Squibb Company
• Genentech
• Gilead
• Novartis
• Vertex Pharmaceuticals Incorporated

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Oncology
• Anti-Viral
• Neurology
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Ambulatory Services

There are 15 Chapters to deeply display the global Breakthrough Therapy Drugs market.

Chapter 1, to describe Breakthrough Therapy Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Breakthrough Therapy Drugs, with sales, revenue, and price of Breakthrough Therapy Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Breakthrough Therapy Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Breakthrough Therapy Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Breakthrough Therapy Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Breakthrough Therapy Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Oncology
  1.2.2 Anti-Viral
  1.2.3 Neurology
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Ambulatory Services
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Business Overview
  2.1.2 Breakthrough Therapy Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Merck Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
  2.2.1 Business Overview
  2.2.2 Breakthrough Therapy Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Pfizer Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AbbVie
  2.3.1 Business Overview
  2.3.2 Breakthrough Therapy Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 AbbVie Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb Company
  2.4.1 Business Overview
  2.4.2 Breakthrough Therapy Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genentech
  2.5.1 Business Overview
  2.5.2 Breakthrough Therapy Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Genentech Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Gilead
  2.6.1 Business Overview
  2.6.2 Breakthrough Therapy Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Gilead Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
  2.7.1 Business Overview
  2.7.2 Breakthrough Therapy Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Novartis Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Vertex Pharmaceuticals Incorporated
  2.8.1 Business Overview
  2.8.2 Breakthrough Therapy Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BREAKTHROUGH THERAPY DRUGS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Breakthrough Therapy Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Breakthrough Therapy Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Breakthrough Therapy Drugs Manufacturer Market Share in 2017
  3.3.2 Top 6 Breakthrough Therapy Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL BREAKTHROUGH THERAPY DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Breakthrough Therapy Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Breakthrough Therapy Drugs Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Breakthrough Therapy Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
4.5 South America Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

5 NORTH AMERICA BREAKTHROUGH THERAPY DRUGS BY COUNTRIES

5.1 North America Breakthrough Therapy Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Breakthrough Therapy Drugs Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Breakthrough Therapy Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

6 EUROPE BREAKTHROUGH THERAPY DRUGS BY COUNTRIES

6.1 Europe Breakthrough Therapy Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Breakthrough Therapy Drugs Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Breakthrough Therapy Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
6.3 UK Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
6.4 France Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC BREAKTHROUGH THERAPY DRUGS BY COUNTRIES

7.1 Asia-Pacific Breakthrough Therapy Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Breakthrough Therapy Drugs Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Breakthrough Therapy Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
7.5 India Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA BREAKTHROUGH THERAPY DRUGS BY COUNTRIES

8.1 South America Breakthrough Therapy Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Breakthrough Therapy Drugs Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Breakthrough Therapy Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA BREAKTHROUGH THERAPY DRUGS BY COUNTRIES

9.1 Middle East and Africa Breakthrough Therapy Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Breakthrough Therapy Drugs Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Breakthrough Therapy Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)

10 GLOBAL BREAKTHROUGH THERAPY DRUGS MARKET SEGMENT BY TYPE

10.1 Global Breakthrough Therapy Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Breakthrough Therapy Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Breakthrough Therapy Drugs Revenue and Market Share by Type (2013-2018)
10.2 Oncology Sales Growth and Price
  10.2.1 Global Oncology Sales Growth (2013-2018)
  10.2.2 Global Oncology Price (2013-2018)
10.3 Anti-Viral Sales Growth and Price
  10.3.1 Global Anti-Viral Sales Growth (2013-2018)
  10.3.2 Global Anti-Viral Price (2013-2018)
10.4 Neurology Sales Growth and Price
  10.4.1 Global Neurology Sales Growth (2013-2018)
  10.4.2 Global Neurology Price (2013-2018)
10.5 Others Sales Growth and Price
  10.5.1 Global Others Sales Growth (2013-2018)
  10.5.2 Global Others Price (2013-2018)

11 GLOBAL BREAKTHROUGH THERAPY DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Breakthrough Therapy Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Ambulatory Services Sales Growth (2013-2018)

12 BREAKTHROUGH THERAPY DRUGS MARKET FORECAST (2018-2023)

12.1 Global Breakthrough Therapy Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Breakthrough Therapy Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Breakthrough Therapy Drugs Market Forecast (2018-2023)
  12.2.2 Europe Breakthrough Therapy Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Breakthrough Therapy Drugs Market Forecast (2018-2023)
  12.2.4 South America Breakthrough Therapy Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Breakthrough Therapy Drugs Market Forecast (2018-2023)
12.3 Breakthrough Therapy Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Breakthrough Therapy Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Breakthrough Therapy Drugs Market Share Forecast by Type (2018-2023)
12.4 Breakthrough Therapy Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Breakthrough Therapy Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Breakthrough Therapy Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Breakthrough Therapy Drugs Picture
Table Product Specifications of Breakthrough Therapy Drugs
Figure Global Sales Market Share of Breakthrough Therapy Drugs by Types in 2017
Table Breakthrough Therapy Drugs Types for Major Manufacturers
Figure Oncology Picture
Figure Anti-Viral Picture
Figure Neurology Picture
Figure Others? Picture
Figure Breakthrough Therapy Drugs Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Services Picture
Figure United States Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Breakthrough Therapy Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Breakthrough Therapy Drugs Type and Applications
Table Merck Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Breakthrough Therapy Drugs Type and Applications
Table Pfizer Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Breakthrough Therapy Drugs Type and Applications
Table AbbVie Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Breakthrough Therapy Drugs Type and Applications
Table Bristol-Myers Squibb Company Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Breakthrough Therapy Drugs Type and Applications
Table Genentech Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Breakthrough Therapy Drugs Type and Applications
Table Gilead Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Breakthrough Therapy Drugs Type and Applications
Table Novartis Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Type and Applications
Table Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Breakthrough Therapy Drugs Sales by Manufacturer (2016-2017)
Figure Global Breakthrough Therapy Drugs Sales Market Share by Manufacturer in 2016
Figure Global Breakthrough Therapy Drugs Sales Market Share by Manufacturer in 2017
Table Global Breakthrough Therapy Drugs Revenue by Manufacturer (2016-2017)
Figure Global Breakthrough Therapy Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Breakthrough Therapy Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Breakthrough Therapy Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Breakthrough Therapy Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Global Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table Global Breakthrough Therapy Drugs Sales by Regions (2013-2018)
Table Global Breakthrough Therapy Drugs Sales Market Share by Regions (2013-2018)
Table Global Breakthrough Therapy Drugs Revenue by Regions (2013-2018)
Figure Global Breakthrough Therapy Drugs Revenue Market Share by Regions in 2013
Figure Global Breakthrough Therapy Drugs Revenue Market Share by Regions in 2017
Figure North America Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Europe Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure South America Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure North America Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table North America Breakthrough Therapy Drugs Sales by Countries (2013-2018)
Table North America Breakthrough Therapy Drugs Sales Market Share by Countries (2013-2018)
Figure North America Breakthrough Therapy Drugs Sales Market Share by Countries in 2013
Figure North America Breakthrough Therapy Drugs Sales Market Share by Countries in 2017
Table North America Breakthrough Therapy Drugs Revenue by Countries (2013-2018)
Table North America Breakthrough Therapy Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Breakthrough Therapy Drugs Revenue Market Share by Countries in 2013
Figure North America Breakthrough Therapy Drugs Revenue Market Share by Countries in 2017
Figure United States Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Canada Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Europe Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table Europe Breakthrough Therapy Drugs Sales by Countries (2013-2018)
Table Europe Breakthrough Therapy Drugs Sales Market Share by Countries (2013-2018)
Table Europe Breakthrough Therapy Drugs Revenue by Countries (2013-2018)
Figure Europe Breakthrough Therapy Drugs Revenue Market Share by Countries in 2016
Figure Europe Breakthrough Therapy Drugs Revenue Market Share by Countries in 2017
Figure Germany Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure UK Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure France Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Russia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Italy Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Breakthrough Therapy Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Breakthrough Therapy Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Breakthrough Therapy Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Breakthrough Therapy Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Breakthrough Therapy Drugs Revenue Market Share by Countries 2017
Figure China Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Japan Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Korea Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure India Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure South America Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table South America Breakthrough Therapy Drugs Sales by Countries (2013-2018)
Table South America Breakthrough Therapy Drugs Sales Market Share by Countries (2013-2018)
Figure South America Breakthrough Therapy Drugs Sales Market Share by Countries in 2017
Table South America Breakthrough Therapy Drugs Revenue by Countries (2013-2018)
Table South America Breakthrough Therapy Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Breakthrough Therapy Drugs Revenue Market Share by Countries in 2017
Figure Brazil Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Breakthrough Therapy Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Breakthrough Therapy Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Breakthrough Therapy Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Breakthrough Therapy Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Breakthrough Therapy Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Breakthrough Therapy Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Breakthrough Therapy Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Breakthrough Therapy Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure UAE Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Breakthrough Therapy Drugs Sales and Growth Rate (2013-2018)
Table Global Breakthrough Therapy Drugs Sales by Type (2013-2018)
Table Global Breakthrough Therapy Drugs Sales Share by Type (2013-2018)
Table Global Breakthrough Therapy Drugs Revenue by Type (2013-2018)
Table Global Breakthrough Therapy Drugs Revenue Share by Type (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Oncology Price (2013-2018)
Figure Global Anti-Viral Sales Growth (2013-2018)
Figure Global Anti-Viral Price (2013-2018)
Figure Global Neurology Sales Growth (2013-2018)
Figure Global Neurology Price (2013-2018)
Figure Global Others? Sales Growth (2013-2018)
Figure Global Others? Price (2013-2018)
Table Global Breakthrough Therapy Drugs Sales by Application (2013-2018)
Table Global Breakthrough Therapy Drugs Sales Share by Application (2013-2018)
Figure Global Clinics Sales Growth (2013-2018)
Figure Global Ambulatory Services Sales Growth (2013-2018)
Figure Global Breakthrough Therapy Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Breakthrough Therapy Drugs Sales Forecast by Regions (2018-2023)
Table Global Breakthrough Therapy Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Breakthrough Therapy Drugs Market Forecast (2018-2023)
Figure Europe Sales Breakthrough Therapy Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Breakthrough Therapy Drugs Market Forecast (2018-2023)
Figure South America Sales Breakthrough Therapy Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Breakthrough Therapy Drugs Market Forecast (2018-2023)
Table Global Breakthrough Therapy Drugs Sales Forecast by Type (2018-2023)
Table Global Breakthrough Therapy Drugs Market Share Forecast by Type (2018-2023)
Table Global Breakthrough Therapy Drugs Sales Forecast by Application (2018-2023)
Table Global Breakthrough Therapy Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List